{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:13:28Z","timestamp":1760184808452,"version":"build-2065373602"},"reference-count":209,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.hoc.2010.06.002","type":"journal-article","created":{"date-parts":[[2010,9,5]],"date-time":"2010-09-05T04:32:06Z","timestamp":1283661126000},"page":"861-883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genitourinary Cancer Predisposition Syndromes"],"prefix":"10.1016","volume":"24","author":[{"given":"David J.","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Feifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2010.06.002_bib1","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2010.06.002_bib2","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/86.21.1600","article-title":"Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands","volume":"86","author":"Goldgar","year":"1994","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.5858\/133.7.1033","article-title":"Molecular biology underlying the clinical heterogeneity of prostate cancer: an update","volume":"133","author":"Mackinnon","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.hoc.2010.06.002_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2010.06.002_bib5","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1093\/hmg\/ddh072","article-title":"The complex genetic epidemiology of prostate cancer","volume":"13","author":"Schaid","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib6","first-page":"1484","article-title":"Studies of genetic factors in prostate cancer in a twin population","volume":"152","author":"Gronberg","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1097-0045(19971201)33:4<240::AID-PROS3>3.0.CO;2-L","article-title":"Heredity and prostate cancer: a study of World War II veteran twins","volume":"33","author":"Page","year":"1997","journal-title":"Prostate"},{"key":"10.1016\/j.hoc.2010.06.002_bib8","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.274.5291.1371","article-title":"Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search","volume":"274","author":"Smith","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.hoc.2010.06.002_bib9","first-page":"4707","article-title":"Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1","volume":"57","author":"Gronberg","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2010.06.002_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng823","article-title":"Germline mutations in the ribonuclease L gene in families showing linkage with HPC1","volume":"30","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jnci\/89.13.955","article-title":"Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study","volume":"89","author":"Cooney","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/89.24.1893","article-title":"Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study","volume":"89","author":"Hsieh","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/514853","article-title":"Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24\u201325","volume":"61","author":"McIndoe","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/301745","article-title":"Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign\/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators","volume":"62","author":"Eeles","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s004390000384","article-title":"Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer","volume":"107","author":"Bergthorsson","year":"2000","journal-title":"Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.ejhg.5200592","article-title":"PCAP is the major known prostate cancer predisposing locus in families from south and west Europe","volume":"9","author":"Cancel-Tassin","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1097-0045(20001001)45:2<106::AID-PROS4>3.0.CO;2-H","article-title":"Replication linkage study for prostate cancer susceptibility genes","volume":"45","author":"Suarez","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.hoc.2010.06.002_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/302771","article-title":"Linkage analyses at the chromosome 1 loci 1q24\u201325 (HPC1), 1q42.2\u201343 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer","volume":"66","author":"Berry","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00439-004-1220-9","article-title":"Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees","volume":"116","author":"Farnham","year":"2005","journal-title":"Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/2477","article-title":"Evidence for a prostate cancer susceptibility locus on the X chromosome","volume":"20","author":"Xu","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/302807","article-title":"Combined analysis of hereditary prostate cancer linkage to 1q24\u201325: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics","volume":"66","author":"Xu","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib22","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/301879","article-title":"Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2\u201343","volume":"62","author":"Berthon","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/302342","article-title":"Analysis of chromosome 1q42.2\u201343 in 152 families with high risk of prostate cancer","volume":"64","author":"Gibbs","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib24","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1086\/302287","article-title":"Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36","volume":"64","author":"Gibbs","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/302457","article-title":"No evidence of linkage for chromosome 1q42.2\u201343 in prostate cancer","volume":"65","author":"Whittemore","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<477::AID-CNCR16>3.0.CO;2-K","article-title":"Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations","volume":"86","author":"Gronberg","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/cncr.11262","article-title":"Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis","volume":"97","author":"Zeegers","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib28","first-page":"273","article-title":"Epidemiology of prostate cancer","volume":"47","author":"Haas","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2010.06.002_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1469-1809.2003.00022.x","article-title":"Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother\u2013brother dependence","volume":"67","author":"Valeri","year":"2003","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib30","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1086\/301862","article-title":"Evidence for autosomal dominant inheritance of prostate cancer","volume":"62","author":"Schaid","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0090-4295(00)00891-8","article-title":"Autosomal dominant inheritance of prostate cancer: a confirmatory study","volume":"57","author":"Verhage","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.hoc.2010.06.002_bib32","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1073\/pnas.89.8.3367","article-title":"Mendelian inheritance of familial prostate cancer","volume":"89","author":"Carter","year":"1992","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.hoc.2010.06.002_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.genom.5.061903.180044","article-title":"Finding prostate cancer susceptibility genes","volume":"5","author":"Ostrander","year":"2004","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib34","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.2741\/2374","article-title":"Genetic etiology of hereditary prostate cancer","volume":"12","author":"Langeberg","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.hoc.2010.06.002_bib35","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1464-410X.2007.07130.x","article-title":"Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer","volume":"100","author":"Walz","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.hoc.2010.06.002_bib36","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/1078-0432.CCR-03-0604","article-title":"BRCA mutations and risk of prostate cancer in Ashkenazi Jews","volume":"10","author":"Kirchhoff","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2010.06.002_bib37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/302525","article-title":"The Jewish Ashkenazi founder mutations in the BRCA1\/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer","volume":"65","author":"Hubert","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/bjc.1998.576","article-title":"Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer","volume":"78","author":"Lehrer","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1097-0045(19990801)40:3<172::AID-PROS5>3.0.CO;2-R","article-title":"Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men","volume":"40","author":"Nastiuk","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.hoc.2010.06.002_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1054\/bjoc.2000.1249","article-title":"The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel","volume":"83","author":"Vazina","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/jmg.40.10.787","article-title":"A\u00a0twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology","volume":"40","author":"Giusti","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib42","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2010.06.002_bib43","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer","volume":"91","author":"Warner","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib44","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.bjc.6603929","article-title":"Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer","volume":"97","author":"Agalliu","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib45","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1158\/1055-9965.EPI-07-0137","article-title":"Common variation in the BRCA1 gene and prostate cancer risk","volume":"16","author":"Douglas","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hoc.2010.06.002_bib46","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1158\/1078-0432.CCR-07-5237","article-title":"Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation","volume":"14","author":"Willems","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2010.06.002_bib47","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib48","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium","volume":"91","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/jnci\/djm005","article-title":"Prostate cancer progression and survival in BRCA2 mutation carriers","volume":"99","author":"Tryggvad\u00f3ttir","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.hoc.2010.06.002_bib50","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1078-0432.CCR-09-2871","article-title":"Germline BRCA mutations denote a clinicopathologic subset of prostate cancer","volume":"16","author":"Gallagher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2010.06.002_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2010.06.002_bib52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346094","article-title":"Mutations in CHEK2 associated with prostate cancer risk","volume":"72","author":"Dong","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib53","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/humu.20321","article-title":"Characterization of CHEK2 mutations in prostate cancer","volume":"27","author":"Wu","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hoc.2010.06.002_bib54","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jmg.2006.044974","article-title":"A\u00a0large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer","volume":"43","author":"Cybulski","year":"2006","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib55","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1158\/0008-5472.CAN-04-0341","article-title":"A\u00a0novel founder CHEK2 mutation is associated with increased prostate cancer risk","volume":"64","author":"Cybulski","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2010.06.002_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2008.05.006","article-title":"Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer","volume":"270","author":"Tischkowitz","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.hoc.2010.06.002_bib57","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1086\/340450","article-title":"Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer","volume":"70","author":"Rokman","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1086\/342775","article-title":"A\u00a0novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews","volume":"71","author":"Rennert","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib59","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.1997.03550150055035","article-title":"Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus","volume":"278","author":"Gronberg","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2010.06.002_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1098-2272(200003)18:3<251::AID-GEPI5>3.0.CO;2-X","article-title":"Linkage analysis of 150 high-risk prostate cancer families at 1q24-25","volume":"18","author":"Goode","year":"2000","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.hoc.2010.06.002_bib61","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng.90","article-title":"Multiple newly identified loci associated with prostate cancer susceptibility","volume":"40","author":"Eeles","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib62","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.91","article-title":"Multiple loci identified in a genome-wide association study of prostate cancer","volume":"40","author":"Thomas","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib63","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/ng2022","article-title":"Genome-wide association study of prostate cancer identifies a second risk locus at 8q24","volume":"39","author":"Yeager","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib64","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.444","article-title":"Identification of a new prostate cancer susceptibility locus on chromosome 8q24","volume":"41","author":"Yeager","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib65","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ng.450","article-title":"Identification of seven new prostate cancer susceptibility loci through a genome-wide association study","volume":"41","author":"Eeles","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib66","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ng1999","article-title":"Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24","volume":"39","author":"Gudmundsson","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ng.89","article-title":"Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer","volume":"40","author":"Gudmundsson","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib68","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ng.448","article-title":"Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility","volume":"41","author":"Gudmundsson","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib69","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ng1808","article-title":"A\u00a0common variant associated with prostate cancer in European and African populations","volume":"38","author":"Amundadottir","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib70","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0605832103","article-title":"Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men","volume":"103","author":"Freedman","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.hoc.2010.06.002_bib71","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ng.452","article-title":"Multiple loci on 8q24 associated with prostate cancer susceptibility","volume":"41","author":"Al Olama","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib72","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ng.214","article-title":"Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12","volume":"40","author":"Sun","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2164-9-12","article-title":"Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility","volume":"9","author":"Sole","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.hoc.2010.06.002_bib74","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ng.403","article-title":"The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer","volume":"41","author":"Pomerantz","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib75","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/ng.406","article-title":"The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling","volume":"41","author":"Tuupanen","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib76","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/0008-5472.CAN-03-2502","article-title":"NBS1 is a prostate cancer susceptibility gene","volume":"64","author":"Cybulski","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2010.06.002_bib77","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/ijc.23471","article-title":"Chromosome 8q24 markers: risk of early-onset and familial prostate cancer","volume":"122","author":"Beebe-Dimmer","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib78","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/107327480000700401","article-title":"Molecular mechanisms and pathways in bladder cancer development and progression","volume":"7","author":"Jung","year":"2000","journal-title":"Cancer Control"},{"key":"10.1016\/j.hoc.2010.06.002_bib79","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ejca.2006.02.009","article-title":"Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain","volume":"42","author":"Kogevinas","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib80","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2105\/AJPH.82.7.955","article-title":"Chlorination, chlorination by-products, and cancer: a meta-analysis","volume":"82","author":"Morris","year":"1992","journal-title":"Am J Public Health"},{"key":"10.1016\/j.hoc.2010.06.002_bib81","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/jnci\/djm004","article-title":"Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water","volume":"99","author":"Marshall","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00001648-199801000-00007","article-title":"Drinking water source and chlorination byproducts. I. Risk of bladder cancer","volume":"9","author":"Cantor","year":"1998","journal-title":"Epidemiology"},{"key":"10.1016\/j.hoc.2010.06.002_bib83","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archinte.1956.00250260001001","article-title":"The association of smoking with cancer of the urinary bladder in humans","volume":"98","author":"Lillienfeld","year":"1956","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hoc.2010.06.002_bib84","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.urolonc.2008.02.016","article-title":"Familial and genetic risk of transitional cell carcinoma of the urinary tract","volume":"26","author":"Mueller","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib85","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ijc.10191","article-title":"Familial aggregation of urothelial cell carcinoma","volume":"98","author":"Aben","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib86","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/ijc.23037","article-title":"Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers","volume":"121","author":"Randi","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib87","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/bmj.2.6193.798-b","article-title":"Genetic association with bladder cancer","volume":"2","author":"Cartwright","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.hoc.2010.06.002_bib88","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ijc.2910350602","article-title":"Familial and environmental interactions in bladder cancer risk","volume":"35","author":"Kantor","year":"1985","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib89","first-page":"1649","article-title":"Familial transitional cell carcinoma among the population of Iceland","volume":"157","author":"Kiemeney","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib90","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00001648-199103000-00010","article-title":"Familial aggregation of bladder cancer stratified by smoking status","volume":"2","author":"Kramer","year":"1991","journal-title":"Epidemiology"},{"key":"10.1016\/j.hoc.2010.06.002_bib91","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/1097-0142(19920401)69:7<1776::AID-CNCR2820690721>3.0.CO;2-P","article-title":"Life style and occupational risk factors for bladder cancer in Germany. A case-control study","volume":"69","author":"Kunze","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib92","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cncr.22071","article-title":"Bladder cancer risk as modified by family history and smoking","volume":"107","author":"Lin","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0165-4608(87)90270-6","article-title":"Familial bladder cancer in an oncology clinic","volume":"27","author":"Lynch","year":"1987","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.hoc.2010.06.002_bib94","first-page":"1033","article-title":"Bladder cancer in young women","volume":"123","author":"Piper","year":"1986","journal-title":"Am J\u00a0Epidemiol"},{"key":"10.1016\/j.hoc.2010.06.002_bib95","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib96","first-page":"466","article-title":"Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options","volume":"160","author":"Sijmons","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib97","doi-asserted-by":"crossref","first-page":"8","DOI":"10.6004\/jnccn.2010.0003","article-title":"NCCN clinical practice guidelines in oncology. Colorectal cancer screening","volume":"8","author":"Burt","year":"2010","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.hoc.2010.06.002_bib98","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/bjc.1986.110","article-title":"Second primary neoplasms in patients with retinoblastoma","volume":"53","author":"Draper","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.coc.0000128861.46357.ee","article-title":"Nonocular second primary tumors after retinoblastoma: retrospective study of 111 patients treated by electron beam radiotherapy with or without TEM","volume":"27","author":"Schlienger","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnci\/djh058","article-title":"Lifetime risks of common cancers among retinoblastoma survivors","volume":"96","author":"Fletcher","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2010.06.002_bib101","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrc1697","article-title":"Urothelial tumorigenesis: a tale of divergent pathways","volume":"5","author":"Wu","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib102","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.c.10019","article-title":"Costello syndrome: an overview","volume":"117C","author":"Hennekam","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib103","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat Genet"},{"year":"2006","series-title":"Bladder cancer","author":"Silverman","key":"10.1016\/j.hoc.2010.06.002_bib104"},{"key":"10.1016\/j.hoc.2010.06.002_bib105","first-page":"1239","article-title":"Metabolic gene polymorphism frequencies in control populations","volume":"10","author":"Garte","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hoc.2010.06.002_bib106","first-page":"29","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hoc.2010.06.002_bib107","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(05)67137-1","article-title":"NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses","volume":"366","author":"Garcia-Closas","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2010.06.002_bib108","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/ng.229","article-title":"Sequence variant on 8q24 confers susceptibility to urinary bladder cancer","volume":"40","author":"Kiemeney","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib109","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrg2507","article-title":"Prostate cancer genomics: towards a new understanding","volume":"10","author":"Witte","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib110","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.421","article-title":"Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer","volume":"41","author":"Wu","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib111","first-page":"461","article-title":"Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development","volume":"177","author":"Zbar","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib112","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1073\/pnas.92.14.6459","article-title":"Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations","volume":"92","author":"Duan","year":"1995","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.hoc.2010.06.002_bib113","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 10","key":"10.1016\/j.hoc.2010.06.002_bib114","first-page":"S119","article-title":"The history of von Hippel\u2013Lindau disease","volume":"19","author":"Molino","year":"2006","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.hoc.2010.06.002_bib115","first-page":"72","article-title":"Retinal and central nervous hemangioblastomatosis with visceral changes (von Hippel-Lindau's disease)","volume":"5","author":"Davison","year":"1936","journal-title":"Bull Neurol Instit NY"},{"key":"10.1016\/j.hoc.2010.06.002_bib116","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","article-title":"Von Hippel\u2013Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma","volume":"332","author":"Seizinger","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2010.06.002_bib117","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1517\/14712598.8.6.779","article-title":"Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy","volume":"8","author":"Pfaffenroth","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.hoc.2010.06.002_bib118","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the Von Hippel\u2013Lindau disease (VHL) gene in families from North America, Europe, and Japan","volume":"8","author":"Zbar","year":"1996","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hoc.2010.06.002_bib119","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel\u2013Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2010.06.002_bib120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archopht.125.2.239","article-title":"Genotype\u2013phenotype correlation in von Hippel\u2013Lindau disease with retinal angiomatosis","volume":"125","author":"Wong","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.hoc.2010.06.002_bib121","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib122","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/109065701753145547","article-title":"Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population","volume":"5","author":"Lindor","year":"2001","journal-title":"Genet Test"},{"key":"10.1016\/j.hoc.2010.06.002_bib123","first-page":"1256","article-title":"Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene","volume":"172","author":"Schmidt","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib124","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1158\/1078-0432.CCR-06-0362","article-title":"Presence of phosphorylated hepatocyte growth factor receptor\/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma","volume":"12","author":"Miyata","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2010.06.002_bib125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1566524043359674","article-title":"Hereditary papillary renal carcinoma type I","volume":"4","author":"Dharmawardana","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.hoc.2010.06.002_bib126","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.onc.1201983","article-title":"Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours","volume":"17","author":"Fischer","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.hoc.2010.06.002_bib127","first-page":"311","article-title":"Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.2 and between loci D20S902 and D20S480 at 20q13.2 mark new tumor genes in papillary renal cell carcinoma","volume":"79","author":"Palmedo","year":"1999","journal-title":"Lab Invest"},{"key":"10.1016\/j.hoc.2010.06.002_bib128","first-page":"907","article-title":"Hereditary papillary renal cell carcinoma: clinical studies in 10 families","volume":"153","author":"Zbar","year":"1995","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib129","first-page":"1719","article-title":"Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene","volume":"58","author":"Schmidt","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.hoc.2010.06.002_bib130","first-page":"431","article-title":"Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer","volume":"163","author":"Ornstein","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib131","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1074\/jbc.M705774200","article-title":"c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations","volume":"283","author":"Bellon","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.hoc.2010.06.002_bib132","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","article-title":"Birt\u2013Hogg\u2013Dube syndrome: diagnosis and management","volume":"10","author":"Menko","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib133","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cncr.24230","article-title":"Hereditary kidney cancer: unique opportunity for disease-based therapy","volume":"115","author":"Linehan","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib134","first-page":"393","article-title":"Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt\u2013Hogg\u2013Dube syndrome","volume":"11","author":"Zbar","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hoc.2010.06.002_bib135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","article-title":"Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Wei","year":"2006","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib136","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.2007.054304","article-title":"BHD mutations, clinical and molecular genetic investigations of Birt\u2013Hogg\u2013Dube syndrome: a new series of 50 families and a review of published reports","volume":"45","author":"Toro","year":"2008","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib137","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/path.2139","article-title":"Identification and characterization of Birt\u2013Hogg\u2013Dube associated renal carcinoma","volume":"211","author":"Murakami","year":"2007","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib138","first-page":"1484","article-title":"Chromophobe renal cell carcinoma in a patient with the Birt\u2013Hogg\u2013Dube syndrome","volume":"168","author":"Durrani","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib139","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1440-1827.2005.01813.x","article-title":"Renal oncocytosis","volume":"55","author":"Nagashima","year":"2005","journal-title":"Pathol Int"},{"key":"10.1016\/j.hoc.2010.06.002_bib140","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1365-2133.2009.09134.x","article-title":"Birt\u2013Hogg\u2013Dube syndrome with clear-cell and oncocytic renal tumour and trichoblastoma associated with a novel FLCN mutation","volume":"160","author":"Imada","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.hoc.2010.06.002_bib141","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.prp.2005.03.008","article-title":"Hybrid chromophobe renal cell neoplasm","volume":"201","author":"Mai","year":"2005","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.hoc.2010.06.002_bib142","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1159\/000326022","article-title":"Cytologic and histologic findings in multiple renal hybrid oncocytic tumors in a patient with Birt\u2013Hogg\u2013Dube syndrome: a case report","volume":"50","author":"Adley","year":"2006","journal-title":"Acta Cytol"},{"key":"10.1016\/j.hoc.2010.06.002_bib143","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt\u2013Hogg\u2013Dube syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib144","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.5858\/2006-130-1865-BSCFAG","article-title":"Birt\u2013Hogg\u2013Dube syndrome: clinicopathologic findings and genetic alterations","volume":"130","author":"Adley","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.hoc.2010.06.002_bib145","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1038\/sj.onc.1204703","article-title":"Birt\u2013Hogg\u2013Dube syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12\u2013q11.2","volume":"20","author":"Khoo","year":"2001","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.hoc.2010.06.002_bib146","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jmg.2009.072009","article-title":"Renal tumor suppressor function of the Birt\u2013Hogg\u2013Dube syndrome gene product folliculin","volume":"47","author":"Hudon","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib147","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/323744","article-title":"Birt\u2013Hogg\u2013Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2","volume":"69","author":"Schmidt","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib148","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.3800152","article-title":"Expression of Birt\u2013Hogg\u2013Dube gene mRNA in normal and neoplastic human tissues","volume":"17","author":"Warren","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib149","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt\u2013Hogg\u2013Dube syndrome","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.hoc.2010.06.002_bib150","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","article-title":"Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt\u2013Hogg\u2013Dube syndrome","volume":"76","author":"Schmidt","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib151","doi-asserted-by":"crossref","first-page":"15552","DOI":"10.1073\/pnas.0603781103","article-title":"Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling","volume":"103","author":"Baba","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.hoc.2010.06.002_bib152","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2174\/1566524043359638","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC)","volume":"4","author":"Kiuru","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.hoc.2010.06.002_bib153","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjc.6603547","article-title":"HIF and fumarate hydratase in renal cancer","volume":"96","author":"Sudarshan","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib154","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib155","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archdermatol.2008.517","article-title":"Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer","volume":"144","author":"Stewart","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.hoc.2010.06.002_bib156","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib157","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","article-title":"Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors","volume":"164","author":"Lehtonen","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib158","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/320124","article-title":"Localization of a gene (MCUL1) for\u00a0multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3\u2013q43","volume":"68","author":"Alam","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib159","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1525-1578(10)60574-0","article-title":"Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer","volume":"7","author":"Alam","year":"2005","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.hoc.2010.06.002_bib160","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib161","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1469-1809.2007.00396.x","article-title":"Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC)","volume":"72","author":"Heinritz","year":"2008","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib162","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib163","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","article-title":"Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency","volume":"12","author":"Alam","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib164","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.fertnstert.2006.02.106","article-title":"Aberrant expression of apoptosis proteins and ultrastructural aberrations in uterine leiomyomas from patients with hereditary leiomyomatosis and renal cell carcinoma","volume":"86","author":"Wortham","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.hoc.2010.06.002_bib165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1686","article-title":"Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome","volume":"205","author":"Pollard","year":"2005","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib166","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.humpath.2006.10.011","article-title":"Conventional renal cancer in a patient with fumarate hydratase mutation","volume":"38","author":"Lehtonen","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib167","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/j.seminoncol.2006.06.008","article-title":"Genetic basis of cancer of the kidney","volume":"33","author":"Sudarshan","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib168","first-page":"1814","article-title":"Radio frequency ablation of small renal tumors: intermediate results","volume":"171","author":"Hwang","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib169","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study","volume":"7","author":"Huang","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib170","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1089\/end.2006.0223","article-title":"Radiofrequency-assisted laparoscopic partial nephrectomy: clinical and histologic results","volume":"21","author":"Coleman","year":"2007","journal-title":"J\u00a0Endourol"},{"key":"10.1016\/j.hoc.2010.06.002_bib171","first-page":"895","article-title":"Surgical management of multi-organ visceral tumors in patients with von Hippel\u2013Lindau disease: a single stage approach","volume":"169","author":"Hwang","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib172","doi-asserted-by":"crossref","unstructured":"Grubb RL, Corbin NS, Choyke P, et\u00a0al. Analysis of 3-cm tumor size threshold for intervention in patients with Birt\u2013Hogg\u2013Dub\u00e9 and hereditary papillary renal cancer [abstract 980]. American Urological Association National Conference; 2005.","DOI":"10.1016\/S0022-5347(18)35136-X"},{"key":"10.1016\/j.hoc.2010.06.002_bib173","first-page":"67","article-title":"Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes","volume":"179","author":"Bratslavsky","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib174","first-page":"777","article-title":"Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience","volume":"165","author":"Herring","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.urolonc.2008.12.015","article-title":"Renal carcinoma: minimally invasive surgery of the small renal mass","volume":"27","author":"Pinto","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib176","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MOU.0b013e3283337b76","article-title":"Current status of nephron-sparing robotic partial nephrectomy","volume":"20","author":"Hsieh","year":"2010","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib177","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1586\/14737140.6.12.1745","article-title":"Partial nephrectomy achieves local tumor control and prevents chronic kidney disease","volume":"6","author":"Russo","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.hoc.2010.06.002_bib178","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.117.3.371","article-title":"Clinical characteristics of ocular angiomatosis in von Hippel\u2013Lindau disease and correlation with germline mutation","volume":"117","author":"Webster","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.hoc.2010.06.002_bib179","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jama.300.11.1334","article-title":"Neurologic manifestations of von Hippel\u2013Lindau disease","volume":"300","author":"Butman","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2010.06.002_bib180","first-page":"248","article-title":"Long-term natural history of hemangioblastomas in patients with von Hippel\u2013Lindau disease: implications for treatment","volume":"105","author":"Ammerman","year":"2006","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.hoc.2010.06.002_bib181","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archsurg.137.6.682","article-title":"Pheochromocytomas and paragangliomas in von Hippel\u2013Lindau disease: a role for laparoscopic and cortical-sparing surgery","volume":"137","author":"Baghai","year":"2002","journal-title":"Arch Surg"},{"key":"10.1016\/j.hoc.2010.06.002_bib182","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.urology.2005.01.009","article-title":"Partial adrenalectomy: the National Cancer Institute experience","volume":"66","author":"Diner","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.hoc.2010.06.002_bib183","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.hoc.2010.06.002_bib184","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncponc0773","article-title":"Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma","volume":"4","author":"Refae","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib185","first-page":"2074","article-title":"Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer","volume":"177","author":"Grubb","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.hoc.2010.06.002_bib186","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10689-009-9306-0","article-title":"Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient","volume":"9","author":"Alrashdi","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib187","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncpuro0711","article-title":"Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer\u2013a distinct form of hereditary kidney cancer","volume":"4","author":"Sudarshan","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib188","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.urolonc.2008.11.001","article-title":"The clinical implications of the genetics of renal cell carcinoma","volume":"27","author":"Rosner","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib189","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1200\/JCO.2006.08.4285","article-title":"Biology and genetics of adult male germ cell tumors","volume":"24","author":"Houldsworth","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib190","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.fertnstert.2007.12.026","article-title":"Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects","volume":"89","author":"Sharpe","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.hoc.2010.06.002_bib191","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1086\/498455","article-title":"The Y deletion gr\/gr and susceptibility to testicular germ cell tumor","volume":"77","author":"Nathanson","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib192","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/bjc.1996.173","article-title":"Familial testicular cancer in Norway and southern Sweden","volume":"73","author":"Heimdal","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib193","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.bjc.6601714","article-title":"Familial risk in testicular cancer as a clue to a heritable and environmental aetiology","volume":"90","author":"Hemminki","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib194","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/(SICI)1097-0215(19960529)66:5<627::AID-IJC8>3.0.CO;2-V","article-title":"Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study","volume":"66","author":"Westergaard","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hoc.2010.06.002_bib195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canep.2009.04.015","article-title":"A\u00a0mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome","volume":"33","author":"Giambartolomei","year":"2009","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.hoc.2010.06.002_bib196","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/hmg\/ddi459","article-title":"Genome-wide linkage screen for testicular germ cell tumour susceptibility loci","volume":"15","author":"Crockford","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib197","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(72)91909-5","article-title":"Possible carcinoma-in-situ of the testis","volume":"2","author":"Skakkebaek","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2010.06.002_bib198","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ng.393","article-title":"Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer","volume":"41","author":"Kanetsky","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib199","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ng.394","article-title":"A\u00a0genome-wide association study of testicular germ cell tumor","volume":"41","author":"Rapley","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.hoc.2010.06.002_bib200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2605.1994.tb01225.x","article-title":"Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours","volume":"17","author":"Rajpert-De Meyts","year":"1994","journal-title":"Int J Androl"},{"key":"10.1016\/j.hoc.2010.06.002_bib201","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.1996.14.12.3126","article-title":"Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms","volume":"14","author":"Dieckmann","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2010.06.002_bib202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ncb978","article-title":"Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1","volume":"5","author":"Sasaki","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.hoc.2010.06.002_bib203","first-page":"699","article-title":"Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors","volume":"2","author":"Frolov","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.hoc.2010.06.002_bib204","first-page":"1299","article-title":"Testicular tumors in Carney's complex","volume":"167","author":"Washecka","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2010.06.002_bib205","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ajcp\/74.5.607","article-title":"Large-cell calcifying Sertoli cell tumor of the testis","volume":"74","author":"Proppe","year":"1980","journal-title":"Am J\u00a0Clin Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib206","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0090-4295(94)90251-8","article-title":"Gonadal tumors in disorders of sexual differentiation","volume":"43","author":"Gourlay","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.hoc.2010.06.002_bib207","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM194912292412601","article-title":"Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance","volume":"241","author":"Jeghers","year":"1949","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2010.06.002_bib208","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/PAS.0b013e3180309e33","article-title":"Intratubular large cell hyalinizing Sertoli cell neoplasia of the testis: a report of 8 cases of a distinctive lesion of the Peutz\u2013Jeghers syndrome","volume":"31","author":"Ulbright","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2010.06.002_bib209","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CCO.0b013e32801195eb","article-title":"Carney complex: the first 20 years","volume":"19","author":"Boikos","year":"2007","journal-title":"Curr Opin Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858810000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858810000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:54:56Z","timestamp":1760183696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858810000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":209,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0889858810000912"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2010.06.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genitourinary Cancer Predisposition Syndromes","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2010.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}